Description: Sugammadex (formerly Org 25969; Org-25969; Org25969; trade name: bridion), a synthetic and modified γ-cyclodextrin derivative, is an approved medication for reversing neuromuscular blockade induced by the muscle relaxant agent rocuronium in general anaesthesia. It is a unique neuromuscular reversal drug and the first in a new class of selective relaxant binding agents.

References: Sugammadex and rocuronium-induced anaphylaxis. J Anesth. 2016 Apr;30(2):290-7.

Related CAS #:343306-79-6 (sodium) 343306-71-8 (free form)

纯度：≥98%

CAS：343306-71-8